Cerebras Systems shares have dropped below $100, down nearly 50% year-to-date, due to insider selling, a short report, and doubts about its major customer OpenAI. Despite recent revenue misses and margin pressure, 10 of 11 analysts still rate the stock as a Buy, citing its unique wafer-scale AI chip design and strong growth prospects. The company expects to triple core revenues in 2027 and sees margin recovery starting in Q4 2026. A Wall Street analyst from Craig-Hallum initiated coverage with a Buy rating and a $325 price target, implying potential gains of over 230%. The stock faces risks from customer shifts and execution but has a strong cash position to limit downside.
Despite the sharp year-to-date drop highlighted in the news, Cerebras Systems shares have rebounded somewhat on Pluang, trading at USD 102.00 with a 1-day gain of 5.85% as of Nov 03, 2026 23:02 WIB. The stock remains far below its 52-week high of USD 311.07 but above its low of USD 96.36. Notably, Pluang users show a strong selling bias with 91% of orders to sell and only 9% to buy, reflecting ongoing caution among investors.
Cerebras Systems is transforming from an AI chip provider to a broader cloud infrastructure player, partnering with companies like OpenAI, AWS, AMD, and Oracle. The company has secured over 600MW of capacity, supporting management's forecast of more ...
Zone Frontier announced progress on its Minnesota data center with revenue expected in Q1 2027 and full capacity by Q2 2027, supported by a 10-year contract with Cerebras Systems. The company completed a 1-for-60 reverse stock split and exited its le...
